Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Oct 1 executedOct 1, 2026 disclosed
ATYR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · ATYR
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
aTYR PHARMA INC — Employee Stock Option (right to buy)
Ticker
ATYR
Shares
410.0K
Price per share
$0
Execution date (reported)
Oct 1, 2026
Owned after transaction
410.0K shares
Days from execution to publication
0
What this establishes
Yaras Brandon filed this Form 4 reporting a grant or award of ATYR on Oct 1, 2026. It became public on Oct 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Yaras Brandoncik:0002156611
Issuer
aTYR PHARMA INCcik:0001339970
Revision history · 0
No field has changed since this record was first ingested.
